Report cover image

Blood Products Market, By Product Category (Whole Blood, Blood Components and Plasma-derived Products), By Application (Hematology, Immunology, Neurology, Oncology, Hematology, and Others), By Technology (Manual Blood Collection and Processing, Automated

Published Jun 09, 2025
Length 140 Pages
SKU # CMI20173616

Description

The Global Blood Products Market is estimated to be valued at USD 38.20 Bn in 2025 and is expected to reach USD 52.69 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032.

The global blood products market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, the rising demand for blood transfusions, and advancements in blood processing and storage technologies. Blood products, including whole blood, red blood cells, platelets, plasma, and other derivatives, play a crucial role in various medical procedures and treatments. The market encompasses a wide range of products such as albumin, immunoglobulins, coagulation factors, and other plasma-derived products. As the global healthcare industry continues to evolve and the demand for life-saving blood products rises, the blood products market is poised for substantial growth in the coming years.

Market Dynamics:

The global blood products market is influenced by several key factors that drive its growth, restrain its expansion, and present opportunities for stakeholders. One of the primary drivers of the market is the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and hematological conditions, which often require blood transfusions and other blood-related treatments. Additionally, the growing geriatric population worldwide, coupled with the rising incidence of surgical procedures, contributes to the heightened demand for blood products. However, the market also faces certain restraints, including the high costs associated with blood collection, processing, and storage, as well as the risk of transfusion-transmitted infections. Moreover, stringent regulatory requirements and the limited shelf life of blood products pose challenges to market growth. Despite these restraints, the blood products market presents significant opportunities for growth, such as the development of advanced blood processing technologies, the increasing adoption of automation in blood banks, and the expansion of plasma-derived therapies. Furthermore, the rising demand for blood products in emerging economies, driven by improving healthcare infrastructure and increasing healthcare expenditure, offers substantial growth prospects for market players.

Key Features of the Study:
  • This report provides in-depth analysis of the global blood products market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood products market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Grifols, CSL Behring, Fresenius Kabi, Octapharma, Takeda Pharmaceutical Company, Sanofi, Kedrion Biopharma, Biotest AG, Mitsubishi Tanabe Pharma Corporation, HemaCare, BloodCenter of Wisconsin, Terumo BCT, Prothera Biosciences, American Red Cross, and Vitalant
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global blood products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood products market
Market Segmentation
  • Product Category Insights (Revenue, USD Bn, 2020 - 2032)
  • Whole Blood
  • Blood Components
  • Red Blood Cells (RBCs)
  • Platelets
  • Plasma
  • White Blood Cells (WBCs)
  • Cryoprecipitate
  • Plasma-derived Products
  • Immunoglobulins
  • Albumin
  • Coagulation Factors
  • Hyperimmune Globulins
  • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Hematology
  • Immunology
  • Neurology
  • Oncology
  • Hematology
  • Others
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Manual Blood Collection and Processing
  • Automated Blood Collection Systems
  • Blood Fractionation and Plasma Separation
  • Pathogen Reduction Technologies
  • Precision Blood Typing and Grouping Systems
  • Others
  • Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
  • Pediatric Patients
  • Adult Patients
  • Geriatric Patients
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Blood Banks
  • Ambulatory Surgical Centers
  • Transfusion Centers
  • Diagnostic Laboratories
  • Research Institutions
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Grifols
  • CSL Behring
  • Fresenius Kabi
  • Octapharma
  • Takeda Pharmaceutical Company
  • Sanofi
  • Kedrion Biopharma
  • Biotest AG
  • Mitsubishi Tanabe Pharma Corporation
  • HemaCare
  • BloodCenter of Wisconsin
  • Terumo BCT
  • Prothera Biosciences
  • American Red Cross
  • Vitalant

Table of Contents

140 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Blood Products Market, By Product Category
Global Blood Products Market, By Application
Global Blood Products Market, By Technology
Global Blood Products Market, By Patient Demographics
Global Blood Products Market, By End User
Global Blood Products Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Blood Products Market, By Product Category, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Whole Blood
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Components
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Red Blood Cells (RBCs)
Platelets
Plasma
White Blood Cells (WBCs)
Cryoprecipitate
Plasma-derived Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunoglobulins
Albumin
Coagulation Factors
Hyperimmune Globulins
Others
5. Global Blood Products Market, By Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hematology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Blood Products Market, By Technology, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Manual Blood Collection and Processing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Automated Blood Collection Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Fractionation and Plasma Separation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pathogen Reduction Technologies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Precision Blood Typing and Grouping Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Blood Products Market, By Patient Demographics, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pediatric Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Blood Products Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Banks
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transfusion Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Blood Products Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Product Category, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Grifols
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
CSL Behring
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fresenius Kabi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Octapharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Takeda Pharmaceutical Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Kedrion Biopharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Biotest AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mitsubishi Tanabe Pharma Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
HemaCare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
BloodCenter of Wisconsin
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Terumo BCT
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Prothera Biosciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
American Red Cross
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Vitalant
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on 'Blood Products Market' - Global forecast to 2032
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.